Predictors of transition from relapsing‑remitting multiple sclerosis to secondary progressive

Abstract

Currently, the multiple sclerosis (MS) is the second most common cause of disability in young people after injury [1]. Approximately 85 % of patients with MS have a relapsing course, which in a half of cases occurs within 15–20 years, culminating in steady progression with or without activity remaining in the form of an exacerbation or new active foci. Diagnosis of secondary progressive MS (SPMS) is difficult and the diagnosis of SPMS is made retrospectively. Therefore, in our article, we considered options for reliable and objective biomarkers that are natural predictors of conversion and are sources for long-term prediction of diseases.